Curaleaf : January Investor Presentation

The world's leading cannabis company

Investor Presentation

CSE: CURA / OTCQX: CURLF

1

1

2

3

4

Q3'22 Highlights

Strategy and Differentiation

Our Track Record

The Cannabis Industry Opportunity

2

Q3'22 Financial and

Operating Highlights

3

1

HIGHLIGHTSOPERATING`

Q3'22 ANDFINANCIAL

Investment Highlights

• The cannabis industry is a generational wealth opportunity, expected to grow from $27 billion in 2022 to $42 billion by 2026, a CAGR of 11%(1)
• Our US and international footprints position us as a global industry leader
• We have a world-classmanagement team with decades of experience
• We are committed to developing highly formulated products backed by science
• We have one of the strongest balance sheets in the industry with total liquidity of $198 million as of quarter end
• Attractive financial model - Strong YoY revenue growth of 7% and Adj. EBITDA YoY growth of 18%
• Multiple levers to improve profitability & cash flow
• Expecting a substantial reduction in 2023 CapEx as our US footprint is largely built out

4

1. BDS Analytics, September 2022.

1 Q3'22 Financial and Operating Highlights

Operating in	26 cultivation
21	(1)	states
	sites

$ 84m

adj. EBITDA

400m(2)

addressable population

145(1) retail

locations

2,000+

wholesale partner accounts

1. As of 12.20.22.
2. Estimated population 21 years and above in states and countries where Curaleaf operates.
3. Includes Curaleaf International cultivation facilities.

≈4.4m(3)

sqft cultivation capacity

$340m

revenue

7%

YoY revenue growth

18%

adj. EBITDA YoY growth

76/23%

retail / wholesale revenue mix

$198m

liquidity

5